Immunotherapy for Guillain-Barré syndrome.
Autor(es): van Doorn Pieter A.; van Koningsveld Rinske
Imprenta: The Lancet. Neurology, v. 3, n. 2, p. 84, 2004
Identificador do objeto digital: 10.1016/S1474-4422(03)00660-4
Descritores: Guillain-Barre Syndrome - Proteins ; Guillain-Barre Syndrome - Antibodies ; Guillain-Barre Syndrome - Public health
Data de publicação: 2004